NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » Haselmeier self-injection devices go connected

a leading developer and manufacturer of innovative self-injection devices


Haselmeier self-injection devices go connected

Haselmeier has added connectivity to its devices portfolio with the announcement of its new Axis-D-Connect Disposable Pen Injector. Haselmeier has partnered with the Austrian Institute of Technology GmbH (AIT) to equip its Axis-D platform pen with AIT`s cartridge fill-level measurement system. The innovative and patented technology provides a simple and intuitive solution for patients while creating an integrated device solution with a range of features that include: device ID and authentication, electronic health record (HER) integration and remote physician monitoring and interaction. All features which are designed to support better therapy adherence and improved patient outcomes.

Based on NFC (Near Field Communication) the fill level and dose measurement technology can be realized without the need to integrate a battery. Using the highest possible degree of integration, a single chip enables very small and cost effective solutions for various applications. All measured data is transferred wirelessly to the end users’ mobile device (smartphone, tablet or smart watch). Using this technology keeps the patient and the physician best informed about the delivered dose and other drug-related information and therefore provides the basis for improving therapy outcomes.

Frédéric Gabriel, chief strategy officer for Haselmeier explains that "This technology will allow Haselmeier to provide more integrated drug delivery solutions to its pharmaceutical partners across both our disposable and reusable injection device portfolios." He continues to explain that "Connected devices will define a new paradigm for improved treatment compliance and control of both chronic and acute diseases."

Manfred Bammer, head of business unit biomedical systems, Health & Environment Department at the Austrian Institute of Technology GmbH adds "AIT and Haselmeier work together as strategic partners in order to bring forward the integration of the fill level measurement technology and together we can define and develop connected injector solutions for customers and patients."

Haselmeier and AIT have straited user evaluation studies in order to fine-time user experience according to the needs and requirements of very different indication fields. The flexibility of this technology and platform enables to adjust Axis-D Connect to user requirements and expectations.

For more information, please visit www.ait.ac.at.

Contact a leading developer and manufacturer of innovative self-injection devices

a leading developer and manufacturer of innovative self-injection devices